Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa.

Sebastiano V, Zhen HH, Haddad B, Bashkirova E, Melo SP, Wang P, Leung TL, Siprashvili Z, Tichy A, Li J, Ameen M, Hawkins J, Lee S, Li L, Schwertschkow A, Bauer G, Lisowski L, Kay MA, Kim SK, Lane AT, Wernig M, Oro AE.

Sci Transl Med. 2014 Nov 26;6(264):264ra163. doi: 10.1126/scitranslmed.3009540. Erratum in: Sci Transl Med. 2014 Dec 17;6(267):267er8. Derafshi, Bahareh Haddad [corrected to Haddad, Bahareh].

2.

Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.

Grandchamp N, Altémir D, Philippe S, Ursulet S, Pilet H, Serre MC, Lenain A, Serguera C, Mallet J, Sarkis C.

PLoS One. 2014 Jun 23;9(6):e99649. doi: 10.1371/journal.pone.0099649. eCollection 2014.

3.

New applications for phage integrases.

Fogg PC, Colloms S, Rosser S, Stark M, Smith MC.

J Mol Biol. 2014 Jul 29;426(15):2703-16. doi: 10.1016/j.jmb.2014.05.014. Epub 2014 May 22. Review.

4.

PhiC31 integrase induces efficient site-specific recombination in the Capra hircus genome.

Ma H, Ma Q, Lu Y, Wang J, Hu W, Gong Z, Cai L, Huang Y, Huang SZ, Zeng F.

DNA Cell Biol. 2014 Aug;33(8):484-91. doi: 10.1089/dna.2013.2124. Epub 2014 Apr 22.

5.

Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.

Sivalingam J, Phan TT, Kon OL.

Gene Ther. 2014 Apr;21(4):402-12. doi: 10.1038/gt.2014.11. Epub 2014 Feb 20.

6.

Expanding the scope of site-specific recombinases for genetic and metabolic engineering.

Gaj T, Sirk SJ, Barbas CF 3rd.

Biotechnol Bioeng. 2014 Jan;111(1):1-15. doi: 10.1002/bit.25096. Epub 2013 Sep 13. Review.

7.

Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells.

Wilber A, Ulloa Montoya F, Hammer L, Moriarity BS, Geurts AM, Largaespada DA, Verfaillie CM, McIvor RS, Lakshmipathy U.

Stem Cells Int. 2011;2011:717069. doi: 10.4061/2011/717069. Epub 2011 Oct 2.

8.

Mutational analysis of highly conserved residues in the phage phiC31 integrase reveals key amino acids necessary for the DNA recombination.

Liu S, Ma J, Wang W, Zhang M, Xin Q, Peng S, Li R, Zhu H.

PLoS One. 2010 Jan 25;5(1):e8863. doi: 10.1371/journal.pone.0008863.

9.

Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity.

Woodard LE, Hillman RT, Keravala A, Lee S, Calos MP.

Gene Ther. 2010 Feb;17(2):217-26. doi: 10.1038/gt.2009.136. Epub 2009 Oct 22.

10.

Mutational derivatives of PhiC31 integrase with increased efficiency and specificity.

Keravala A, Lee S, Thyagarajan B, Olivares EC, Gabrovsky VE, Woodard LE, Calos MP.

Mol Ther. 2009 Jan;17(1):112-20. doi: 10.1038/mt.2008.241. Epub 2008 Nov 11.

11.

Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.

Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):419-24. Epub 2005 Dec 30.

13.

Targeting site-specific chromosome integration.

Nuno-Gonzalez P, Chao H, Oka K.

Acta Biochim Pol. 2005;52(2):285-91. Epub 2005 Jun 3. Review.

14.

Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31.

Groth AC, Fish M, Nusse R, Calos MP.

Genetics. 2004 Apr;166(4):1775-82.

15.

Phage integrases for the construction and manipulation of transgenic mammals.

Hollis RP, Stoll SM, Sclimenti CR, Lin J, Chen-Tsai Y, Calos MP.

Reprod Biol Endocrinol. 2003 Nov 7;1:79.

Supplemental Content

Support Center